DR
Dharmesh Rameshbhai Kathiriya
About Dharmesh Rameshbhai Kathiriya
Data last updated:
Dharmesh Rameshbhai Kathiriya is a Director at Edges Medicare Private Limited (since 2020) and Director at Omicron Pharma Private Limited (since 2022). The companies operate in Healthcare and Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹8.44 Cr; the largest is Edges Medicare Private Limited at ₹6.34 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Director | 09 Oct 2020 | 2020 | ₹6.34 Cr (FY 2025) | Active | |
| Director | 07 Jun 2022 | 2022 | ₹2.10 Cr (FY 2025) | Active |
Board colleagues of Dharmesh Rameshbhai Kathiriya
| Name | DIN | Company | Designation |
|---|---|---|---|
| Abhaykumar Ashokbhai Tandel | 08906938 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Hemrajbhai Babubhai Anghan | 08911161 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Hiteshkumar Madhubhai Paneliya | 08911160 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
| Monikaben Jatinbhai Patel | 06573822 | Edges Medicare Private Limited , Omicron Pharma Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Dharmesh Rameshbhai Kathiriya
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Dharmesh Rameshbhai Kathiriya
Dharmesh Rameshbhai Kathiriya currently holds 2 directorships: Edges Medicare Private Limited (Director, since 09 Oct 2020, revenue ₹6.34 Cr (FY 2025)); Omicron Pharma Private Limited (Director, since 07 Jun 2022, revenue ₹2.10 Cr (FY 2025)).
Dharmesh Rameshbhai Kathiriya was first appointed on 09 Oct 2020 as Director at Edges Medicare Private Limited. The most recent appointment on record is 07 Jun 2022 at Omicron Pharma Private Limited.
The 2 current companies of Dharmesh Rameshbhai Kathiriya that report revenue have a combined latest revenue of ₹8.44 Cr: Edges Medicare Private Limited ₹6.34 Cr (FY 2025); Omicron Pharma Private Limited ₹2.10 Cr (FY 2025).
The current boards of Dharmesh Rameshbhai Kathiriya's companies include Abhaykumar Ashokbhai Tandel (Edges Medicare Private Limited), Hemrajbhai Babubhai Anghan (Edges Medicare Private Limited), Hiteshkumar Madhubhai Paneliya (Edges Medicare Private Limited), Monikaben Jatinbhai Patel (Edges Medicare Private Limited).